GPT and diabetes mellitus: It is considered an effective biomarker for liver disease screening, especially when the AST/ALT ratio exceeds the limit of 1.15, which is a clinical and preventive standard for cardiovascular diseases, various cancers even type 2 diabetes mellitus [26].